Dose–response between frequency of interruption of sedentary time and fasting glucose, the dawn phenomenon and night-time glucose in Type 2 diabetes

A. C. Paing, K. A. McMillan, A. F. Kirk, A. Collier, A. Hewitt, S. F. M. Chastin

Research output: Contribution to journalArticle

15 Downloads (Pure)

Abstract

Aim: To explore the dose–response between frequency of interruption of sedentary time and basal glucose (fasting glucose, the dawn phenomenon and night-time glucose) in Type 2 diabetes. Methods: In a randomized three-treatment, two-period balanced incomplete block trial, 12 people with Type 2 diabetes (age, 60.0 ± 3.2 years; BMI, 30.2 ± 1.4 kg/m 2 ) completed two of three conditions: sitting for 7 h interrupted every 60 min (Condition 1), 30 min (Condition 2), and 15 min (Condition 3) by 3-min light-intensity walking breaks. The activPAL3 and FreeStyle Libre were used to assess physical activity/sedentary behaviour and continuous glucose profile. Standardized meals were provided, and changes in basal glucose of the nights and early mornings before and after treatment conditions were calculated (mean ± SE). Results: After treatment conditions, fasting glucose and duration of the dawn phenomenon were lower for Condition 3 (−1.0 ± 0.2 mmol/l, P 
Original languageEnglish
Pages (from-to)376-382
Number of pages7
JournalDiabetic Medicine
Volume36
Issue number3
Early online date12 Oct 2018
DOIs
Publication statusPublished - Mar 2019

Fingerprint

Type 2 Diabetes Mellitus
Fasting
Glucose
Walking
Meals
Light

Keywords

  • sedentary behavior
  • glucose
  • type 2 diabetes

Cite this

@article{b47315b7c1c94ab7a0e5ade692e29b17,
title = "Dose–response between frequency of interruption of sedentary time and fasting glucose, the dawn phenomenon and night-time glucose in Type 2 diabetes",
abstract = "Aim: To explore the dose–response between frequency of interruption of sedentary time and basal glucose (fasting glucose, the dawn phenomenon and night-time glucose) in Type 2 diabetes. Methods: In a randomized three-treatment, two-period balanced incomplete block trial, 12 people with Type 2 diabetes (age, 60.0 ± 3.2 years; BMI, 30.2 ± 1.4 kg/m 2 ) completed two of three conditions: sitting for 7 h interrupted every 60 min (Condition 1), 30 min (Condition 2), and 15 min (Condition 3) by 3-min light-intensity walking breaks. The activPAL3 and FreeStyle Libre were used to assess physical activity/sedentary behaviour and continuous glucose profile. Standardized meals were provided, and changes in basal glucose of the nights and early mornings before and after treatment conditions were calculated (mean ± SE). Results: After treatment conditions, fasting glucose and duration of the dawn phenomenon were lower for Condition 3 (−1.0 ± 0.2 mmol/l, P ",
keywords = "sedentary behavior , glucose, type 2 diabetes",
author = "Paing, {A. C.} and McMillan, {K. A.} and Kirk, {A. F.} and A. Collier and A. Hewitt and Chastin, {S. F. M.}",
note = "Acceptance from webpage AAM requested x 2; unable to use VoR uploaded. ET 18/1/19 and 8/2/19 Found article in Strathprints - uploaded AAM. Ask about deposit and access dates. ET",
year = "2019",
month = "3",
doi = "10.1111/dme.13829",
language = "English",
volume = "36",
pages = "376--382",
journal = "Diabetic Medicine",
issn = "0742-3071",
publisher = "John Wiley & Sons",
number = "3",

}

Dose–response between frequency of interruption of sedentary time and fasting glucose, the dawn phenomenon and night-time glucose in Type 2 diabetes. / Paing, A. C.; McMillan, K. A.; Kirk, A. F.; Collier, A.; Hewitt, A.; Chastin, S. F. M.

In: Diabetic Medicine, Vol. 36, No. 3, 03.2019, p. 376-382.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Dose–response between frequency of interruption of sedentary time and fasting glucose, the dawn phenomenon and night-time glucose in Type 2 diabetes

AU - Paing, A. C.

AU - McMillan, K. A.

AU - Kirk, A. F.

AU - Collier, A.

AU - Hewitt, A.

AU - Chastin, S. F. M.

N1 - Acceptance from webpage AAM requested x 2; unable to use VoR uploaded. ET 18/1/19 and 8/2/19 Found article in Strathprints - uploaded AAM. Ask about deposit and access dates. ET

PY - 2019/3

Y1 - 2019/3

N2 - Aim: To explore the dose–response between frequency of interruption of sedentary time and basal glucose (fasting glucose, the dawn phenomenon and night-time glucose) in Type 2 diabetes. Methods: In a randomized three-treatment, two-period balanced incomplete block trial, 12 people with Type 2 diabetes (age, 60.0 ± 3.2 years; BMI, 30.2 ± 1.4 kg/m 2 ) completed two of three conditions: sitting for 7 h interrupted every 60 min (Condition 1), 30 min (Condition 2), and 15 min (Condition 3) by 3-min light-intensity walking breaks. The activPAL3 and FreeStyle Libre were used to assess physical activity/sedentary behaviour and continuous glucose profile. Standardized meals were provided, and changes in basal glucose of the nights and early mornings before and after treatment conditions were calculated (mean ± SE). Results: After treatment conditions, fasting glucose and duration of the dawn phenomenon were lower for Condition 3 (−1.0 ± 0.2 mmol/l, P 

AB - Aim: To explore the dose–response between frequency of interruption of sedentary time and basal glucose (fasting glucose, the dawn phenomenon and night-time glucose) in Type 2 diabetes. Methods: In a randomized three-treatment, two-period balanced incomplete block trial, 12 people with Type 2 diabetes (age, 60.0 ± 3.2 years; BMI, 30.2 ± 1.4 kg/m 2 ) completed two of three conditions: sitting for 7 h interrupted every 60 min (Condition 1), 30 min (Condition 2), and 15 min (Condition 3) by 3-min light-intensity walking breaks. The activPAL3 and FreeStyle Libre were used to assess physical activity/sedentary behaviour and continuous glucose profile. Standardized meals were provided, and changes in basal glucose of the nights and early mornings before and after treatment conditions were calculated (mean ± SE). Results: After treatment conditions, fasting glucose and duration of the dawn phenomenon were lower for Condition 3 (−1.0 ± 0.2 mmol/l, P 

KW - sedentary behavior

KW - glucose

KW - type 2 diabetes

U2 - 10.1111/dme.13829

DO - 10.1111/dme.13829

M3 - Article

VL - 36

SP - 376

EP - 382

JO - Diabetic Medicine

JF - Diabetic Medicine

SN - 0742-3071

IS - 3

ER -